221 related articles for article (PubMed ID: 30228045)
1. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro.
Marshalek JP; Sheeran PS; Ingram P; Dayton PA; Witte RS; Matsunaga TO
J Control Release; 2016 Dec; 243():69-77. PubMed ID: 27686582
[TBL] [Abstract][Full Text] [Related]
3. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):177-191. PubMed ID: 30318123
[TBL] [Abstract][Full Text] [Related]
5. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
Rojas JD; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Vaporised Targeted Nanodroplets Using High-Frame-Rate Ultrasound and Optics.
Zhang G; Lin S; Leow CH; Pang KT; Hernández-Gil J; Long NJ; Eckersley R; Matsunaga T; Tang MX
Ultrasound Med Biol; 2019 May; 45(5):1131-1142. PubMed ID: 30827708
[TBL] [Abstract][Full Text] [Related]
8. Polyvinyl Alcohol Cryogels for Acoustic Characterization of Phase-Change Contrast Agents.
Durham PG; Kim J; Eltz KM; Caskey CF; Dayton PA
Ultrasound Med Biol; 2022 May; 48(5):954-960. PubMed ID: 35246338
[TBL] [Abstract][Full Text] [Related]
9. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
Sheeran PS; Wong VP; Luois S; McFarland RJ; Ross WD; Feingold S; Matsunaga TO; Dayton PA
Ultrasound Med Biol; 2011 Sep; 37(9):1518-30. PubMed ID: 21775049
[TBL] [Abstract][Full Text] [Related]
10. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
[TBL] [Abstract][Full Text] [Related]
12. Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.
Sheeran PS; Streeter JE; Mullin LB; Matsunaga TO; Dayton PA
Ultrasound Med Biol; 2013 May; 39(5):893-902. PubMed ID: 23453380
[TBL] [Abstract][Full Text] [Related]
13. Slow-Flow Ultrasound Localization Microscopy Using Recondensation of Perfluoropentane Nanodroplets.
Burgess MT; Aliabouzar M; Aguilar C; Fabiilli ML; Ketterling JA
Ultrasound Med Biol; 2022 May; 48(5):743-759. PubMed ID: 35125244
[TBL] [Abstract][Full Text] [Related]
14. Phase-change contrast agents for imaging and therapy.
Sheeran PS; Dayton PA
Curr Pharm Des; 2012; 18(15):2152-65. PubMed ID: 22352770
[TBL] [Abstract][Full Text] [Related]
15. Transcranial activation and imaging of low boiling point phase-change contrast agents through the temporal bone using an ultrafast interframe activation ultrasound sequence.
Jing B; Kashyap EP; Lindsey BD
Med Phys; 2020 Sep; 47(9):4450-4464. PubMed ID: 32657429
[TBL] [Abstract][Full Text] [Related]
16. Imaging of vaporised sub-micron phase change contrast agents with high frame rate ultrasound and optics.
Lin S; Zhang G; Jamburidze A; Chee M; Leow CH; Garbin V; Tang MX
Phys Med Biol; 2018 Mar; 63(6):065002. PubMed ID: 29384498
[TBL] [Abstract][Full Text] [Related]
17. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
Puett C; Sheeran PS; Rojas JD; Dayton PA
Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
[TBL] [Abstract][Full Text] [Related]
18. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-Stimulated Phase-Change Contrast Agents for Transepithelial Delivery of Macromolecules, Toward Gastrointestinal Drug Delivery.
Fix SM; Koppolu BP; Novell A; Hopkins J; Kierski TM; Zaharoff DA; Dayton PA; Papadopoulou V
Ultrasound Med Biol; 2019 Jul; 45(7):1762-1776. PubMed ID: 31003709
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
